299 related articles for article (PubMed ID: 30678686)
1. A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo.
Berk M; Turner A; Malhi GS; Ng CH; Cotton SM; Dodd S; Samuni Y; Tanious M; McAulay C; Dowling N; Sarris J; Owen L; Waterdrinker A; Smith D; Dean OM
BMC Med; 2019 Jan; 17(1):18. PubMed ID: 30678686
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-6 and total antioxidant capacity levels following
Bortolasci CC; Voigt C; Turner A; Mohebbi M; Gray L; Dodd S; Walder K; Berk M; Cotton SM; Malhi GS; Ng CH; Dowling N; Sarris J; Dean OM
Acta Neuropsychiatr; 2020 Dec; 32(6):313-320. PubMed ID: 32600481
[TBL] [Abstract][Full Text] [Related]
3. Design and rationale of a 16-week adjunctive randomized placebo-controlled trial of mitochondrial agents for the treatment of bipolar depression.
Dean OM; Turner A; Malhi GS; Ng C; Cotton SM; Dodd S; Sarris J; Samuni Y; Tanious M; Dowling N; Waterdrinker A; Smith D; Berk M
Braz J Psychiatry; 2015; 37(1):3-12. PubMed ID: 25295681
[TBL] [Abstract][Full Text] [Related]
4. The efficacy of adjunctive N-acetylcysteine in major depressive disorder: a double-blind, randomized, placebo-controlled trial.
Berk M; Dean OM; Cotton SM; Jeavons S; Tanious M; Kohlmann K; Hewitt K; Moss K; Allwang C; Schapkaitz I; Robbins J; Cobb H; Ng F; Dodd S; Bush AI; Malhi GS
J Clin Psychiatry; 2014 Jun; 75(6):628-36. PubMed ID: 25004186
[TBL] [Abstract][Full Text] [Related]
5. Effects on health-related quality of life in patients treated with lurasidone for bipolar depression: results from two placebo controlled bipolar depression trials.
Rajagopalan K; Bacci ED; Ng-Mak D; Wyrwich K; Pikalov A; Loebel A
BMC Psychiatry; 2016 May; 16():157. PubMed ID: 27215976
[TBL] [Abstract][Full Text] [Related]
6. N-acetylcysteine as an adjunctive treatment for bipolar depression and major depressive disorder: a systematic review and meta-analysis of double-blind, randomized placebo-controlled trials.
Kishi T; Miyake N; Okuya M; Sakuma K; Iwata N
Psychopharmacology (Berl); 2020 Nov; 237(11):3481-3487. PubMed ID: 32767039
[TBL] [Abstract][Full Text] [Related]
7. N-acetyl cysteine for depressive symptoms in bipolar disorder--a double-blind randomized placebo-controlled trial.
Berk M; Copolov DL; Dean O; Lu K; Jeavons S; Schapkaitz I; Anderson-Hunt M; Bush AI
Biol Psychiatry; 2008 Sep; 64(6):468-75. PubMed ID: 18534556
[TBL] [Abstract][Full Text] [Related]
8. The efficacy of adjunctive N-acetylcysteine in acute bipolar depression: A randomized placebo-controlled study.
Ellegaard PK; Licht RW; Nielsen RE; Dean OM; Berk M; Poulsen HE; Mohebbi M; Nielsen CT
J Affect Disord; 2019 Feb; 245():1043-1051. PubMed ID: 30699846
[TBL] [Abstract][Full Text] [Related]
9. The effect of N-acetylcysteine on bipolar depression: a systematic review and meta-analysis of randomized controlled trials.
Pittas S; Theodoridis X; Haidich AB; Bozikas PV; Papazisis G
Psychopharmacology (Berl); 2021 Jul; 238(7):1729-1736. PubMed ID: 33641060
[TBL] [Abstract][Full Text] [Related]
10. Patient centric measures for a patient centric era: Agreement and convergent between ratings on The Patient Global Impression of Improvement (PGI-I) scale and the Clinical Global Impressions - Improvement (CGI-S) scale in bipolar and major depressive disorder.
Mohebbi M; Dodd S; Dean OM; Berk M
Eur Psychiatry; 2018 Sep; 53():17-22. PubMed ID: 29859377
[TBL] [Abstract][Full Text] [Related]
11. Diet quality, dietary inflammatory index and body mass index as predictors of response to adjunctive
Ashton MM; Dean OM; Marx W; Mohebbi M; Berk M; Malhi GS; Ng CH; Cotton SM; Dodd S; Sarris J; Hopwood M; Faye-Chauhan K; Kim Y; Dash SR; Jacka FN; Shivappa N; Hebert JR; Turner A
Aust N Z J Psychiatry; 2020 Feb; 54(2):159-172. PubMed ID: 31661974
[TBL] [Abstract][Full Text] [Related]
12. A Double-Blind, Randomized, Placebo-Controlled Study of Aspirin and N-Acetylcysteine as Adjunctive Treatments for Bipolar Depression.
Bauer IE; Green C; Colpo GD; Teixeira AL; Selvaraj S; Durkin K; Zunta-Soares GB; Soares JC
J Clin Psychiatry; 2018 Dec; 80(1):. PubMed ID: 30549489
[TBL] [Abstract][Full Text] [Related]
13. A randomized, double-blind, placebo-controlled, proof-of-concept trial of creatine monohydrate as adjunctive treatment for bipolar depression.
Toniolo RA; Silva M; Fernandes FBF; Amaral JAMS; Dias RDS; Lafer B
J Neural Transm (Vienna); 2018 Feb; 125(2):247-257. PubMed ID: 29177955
[TBL] [Abstract][Full Text] [Related]
14. Physical Activity as a Predictor of Clinical Trial Outcomes in Bipolar Depression: A Subanalysis of a Mitochondrial-Enhancing Nutraceutical Randomized Controlled Trial.
Ashton MM; Mohebbi M; Turner A; Marx W; Berk M; Malhi GS; Ng CH; Cotton SM; Dodd S; Sarris J; Hopwood M; Stubbs B; Dean OM
Can J Psychiatry; 2020 May; 65(5):306-318. PubMed ID: 31775518
[TBL] [Abstract][Full Text] [Related]
15. Baseline serum amino acid levels predict treatment response to augmentation with N-acetylcysteine (NAC) in a bipolar disorder randomised trial.
Bortolasci CC; Turner A; Mohebbi M; Liu ZS; Ashton M; Gray L; Marx W; Walker AJ; Kowalski GM; Jacka F; Berk M; Dean OM; Walder K
J Psychiatr Res; 2021 Oct; 142():376-383. PubMed ID: 34438354
[TBL] [Abstract][Full Text] [Related]
16. A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression.
Calabrese JR; Keck PE; Macfadden W; Minkwitz M; Ketter TA; Weisler RH; Cutler AJ; McCoy R; Wilson E; Mullen J
Am J Psychiatry; 2005 Jul; 162(7):1351-60. PubMed ID: 15994719
[TBL] [Abstract][Full Text] [Related]
17. Add-on treatment with N-acetylcysteine for bipolar depression: a 24-week randomized double-blind parallel group placebo-controlled multicentre trial (NACOS-study protocol).
Ellegaard PK; Licht RW; Poulsen HE; Nielsen RE; Berk M; Dean OM; Mohebbi M; Nielsen CT
Int J Bipolar Disord; 2018 Apr; 6(1):11. PubMed ID: 29619634
[TBL] [Abstract][Full Text] [Related]
18. Extended-release quetiapine as monotherapy for the treatment of adults with acute mania: a randomized, double-blind, 3-week trial.
Cutler AJ; Datto C; Nordenhem A; Minkwitz M; Acevedo L; Darko D
Clin Ther; 2011 Nov; 33(11):1643-58. PubMed ID: 22054797
[TBL] [Abstract][Full Text] [Related]
19. Adjunctive minocycline treatment for major depressive disorder: A proof of concept trial.
Dean OM; Kanchanatawan B; Ashton M; Mohebbi M; Ng CH; Maes M; Berk L; Sughondhabirom A; Tangwongchai S; Singh AB; McKenzie H; Smith DJ; Malhi GS; Dowling N; Berk M
Aust N Z J Psychiatry; 2017 Aug; 51(8):829-840. PubMed ID: 28578592
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of lamotrigine as add-on treatment to lithium in bipolar depression: a multicenter, double-blind, placebo-controlled trial.
van der Loos ML; Mulder PG; Hartong EG; Blom MB; Vergouwen AC; de Keyzer HJ; Notten PJ; Luteijn ML; Timmermans MA; Vieta E; Nolen WA;
J Clin Psychiatry; 2009 Feb; 70(2):223-31. PubMed ID: 19200421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
